Quadriga Capital
Also known as Quadriga Capital Eigenkapitalberatung GmbH, Quadriga Capital Funds
Frankfurt mid-market private equity firm advising the Quadriga Capital Funds; majority stakes in DACH healthcare, tech-enabled services and smart industries companies; €20–120m equity tickets.
Frankfurt mid-market private equity adviser to the Quadriga Capital Funds. Not Quadriga Fintech or QuadrigaCX.
- HEADQUARTERS
- Frankfurt am Main, Germany
- FOUNDED
- —
- AUM
- €916M (2021)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 18 people
Focus
- STAGES
- GrowthBuyout
- ASSET MIX
- Private equityImpact
- GEOGRAPHY
- GermanyAustriaSwitzerlandEurope
Overview
Quadriga Capital advises the Quadriga Capital Funds, which take mainly majority stakes in owner-led mid-sized companies in Germany, Austria, Switzerland and neighbouring countries. Its founders around Dr. Andreas Fendel and Max W. Römer helped establish private equity in Germany in the mid-1980s, and it says the funds have backed more than 150 mid-sized growth companies, with more than 50 international institutional investors. It focuses on Healthcare, Tech-Enabled Services and Smart Industries, often via platform and buy-and-build strategies, and publishes sustainability reports as a signatory of the Operating Principles for Impact Management.
Investment thesis
Builds market leaders organically or by buy-and-build in Healthcare, Tech-Enabled Services and Smart Industries: established DACH mid-market companies with €50–300m revenue and €50–250m enterprise value, in megatrend-supported markets with digital-transformation potential and a positive environmental and social impact; mainly majority stakes, qualified minorities in exceptions.
PORTFOLIO (24)
- GBA GroupNOTABLEHealthTech
- SCIO AutomationNOTABLEIndustrial & Manufacturing
- salestech groupSoftware & SaaS
- HealthTech
- NewcareHealthTech
- GIG Gesellschaft für integrierte GesundheitsversorgungHealthTech
- IpsenIndustrial & Manufacturing
- KineticsIndustrial & Manufacturing · Exited
- Aspire EducationEducation · Exited
- AliconaIndustrial & Manufacturing · Exited
- M+R AutomationIndustrial & Manufacturing · Exited
- KrankenhausgruppeHealthTech · Exited
- Dorea FamilieHealthTech · Exited
- AHTIndustrial & Manufacturing · Exited
- LEWA Pumps & SystemsIndustrial & Manufacturing · Exited
- Lapp InsulatorsIndustrial & Manufacturing · Exited
- PunkerIndustrial & Manufacturing · Exited
- CoventyaIndustrial & Manufacturing · Exited
- EssmannIndustrial & Manufacturing · Exited
- Francotyp-PostaliaIndustrial & Manufacturing · Exited
- Saia-Burgess ControlsIndustrial & Manufacturing · Exited
- UsterIndustrial & Manufacturing · Exited
- ZTK ZahngesundheitHealthTech · Exited
- Hedrich GroupIndustrial & Manufacturing · Exited
People
- Philipp JacobiManaging Partner · source
- Jörg MugrauerManaging Partner · source
- Dr. Philip MatlachowskyPartner · source
- Thomas RenderPartner · source
- Sven HoffmannDirector · source
- Deniz VaranSenior Investment Manager · source
- Philipp RosenbachInvestment Manager · source
- Dr. Violetta SulzbachSustainability & Operations Manager · source
- Jasper von RichthofenChief Operating Officer · source
- Dr. Marina MartiniChairwoman Healthcare Board · source
- Norbert MüllerChairman Senior Executive Board · source
- Prof. Dr. Herwig BuchholzChairman Impact Advisory Board · source
- Prof. Dr. Thomas BauernhanslChairman Digital Board · source
- Reinhard SchingsHealthcare Board · source
- Jan WeidnerSenior Advisor · source
- Alice DrooghmansImpact Advisory Board · source
- Joanna RadekeImpact Advisory Board · source
- Prof. Dr. Torsten KrögerDigital Board · source
Links
Frequently asked questions
Quadriga Capital is a private equity fund based in Frankfurt am Main, Germany.
Yes. Quadriga Capital invests its own capital in private companies.
Quadriga Capital invests at Growth and Buyout stages in HealthTech, Software & SaaS and Industrial & Manufacturing.
Quadriga Capital's stated ticket size is €20M–€120M.
Key people at Quadriga Capital include Philipp Jacobi (Managing Partner), Jörg Mugrauer (Managing Partner), Dr. Philip Matlachowsky (Partner) and Thomas Render (Partner).
Quadriga Capital's investments include GBA Group, SCIO Automation, salestech group, UNITED THERAPY, Newcare, GIG Gesellschaft für integrierte Gesundheitsversorgung, Ipsen and Kinetics, among others.
The most recent publicly reported investment by Quadriga Capital is Johner Institut (add-on to GBA Group) (Add-on acquisition), announced in Mar 2026.
Yes. Quadriga Capital manages capital from outside investors.